Romero, F. Anthony
Unity Biotechnology (United States)
3 papers on CoChatORCID 0000-0001-7917-1459
Most cited papers
- Verified
Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation
Raisner, R., Kharbanda, S., Jin, L., Jeng, E., Chan, E., Merchant, M., Haverty, P. M., Bainer, R., Cheung, T., Arnott, D., et al. (2018) · Cell Reports
Genomics and Chromatin DynamicsChromatin Remodeling and Cancer
Cited by 375
- Verified
Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer
Jin, L., Garcia, J., Chan, E., de la Cruz, C., Segal, E., Merchant, M., Kharbanda, S., Raisner, R., Haverty, P. M., Modrusan, Z., et al. (2017) · Cancer Research
Prostate Cancer Treatment and ResearchProtein Degradation and Inhibitors
Cited by 153
- Verified
Discovery of MK-8722: A systemic, direct pan-activator of amp-activated protein kinase
Feng, D., Biftu, T., Romero, F. A., Kekec, A., Dropinski, J., Kassick, A., Xu, S., Kurtz, M. M., Gollapudi, A., Shao, Q., et al. (2018) · ACS Medicinal Chemistry Letters
Metabolism, Diabetes, and CancerNatural Antidiabetic Agents Studies
Cited by 64
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free